The Clasado Biosciences team will be at CPHI Milan 2026 from 6 – 7 October, bringing its expertise in prebiotic science to one of the pharmaceutical industry’s largest international events.
Held at Fiera Milano, CPHI Milan brings together more than 60,000 professionals and 2,400 exhibitors from 150 countries, providing a global forum for companies working across pharma ingredients, formulation, manufacturing, and consumer health.
For Clasado, the event provides an opportunity to meet with brand owners, formulators, and industry partners interested in exploring the potential of prebiotics to support the next generation of health products, supplements and nutraceuticals
The Clasado team will be available throughout the event to discuss Bimuno® GOS, the company’s proprietary prebiotic galactooligosaccharide and the evolving consumer insights related to in fibers and biotics. Now supported by more than 135 scientific publications, including over 25 clinical studies, Bimuno® GOS has an extensive evidence base spanning gastrointestinal, immune and brain health
A particular area of interest for brands is the ingredient’s demonstrated efficacy at ultra-low doses, with research showing a bifidogenic effect from just 380mg of active Bimuno® GOS per day. This can create additional possibilities for compact formats, including capsules and tablets.
Annika Malmros, Director of Business Development at Clasado, commented: “CPHI provides a valuable opportunity to connect with the pharmaceutical and consumer health community and understand where formulators see the greatest opportunities for innovation. Prebiotic science is becoming very relevant across a broad range of health categories. We are looking forward to sharing how the evidence behind Bimuno® GOS can support the development of differentiated science-led products across Europe.”
Annika continued: “For brands, the science behind an ingredient is only part of the equation. Practical considerations such as dose, ability to work fast, format and formulation flexibility are equally important. Our science supporting Bimuno® GOS demonstrates how strong scientific substantiation can translate into new possibilities for product development, particularly where space is at a premium.”
As Clasado continues to expand the scientific and commercial application of Bimuno® GOS, CPHI Milan will provide an opportunity to explore new partnerships and discuss the evolving role of prebiotics in consumer health and nutraceutical formulation.
Those interested in arranging a one-on-one meeting with Annika Malmros at CPHI Milan can contact the Clasado team in advance via the contact form Contact us – Clasado Biosciences
